Our observation of conserved NKX3.1 binding elements in the TMPRSS2 promoter prompted us to examine the hypothesis that NKX3.1 is a repressor of ERG in the TMPRSS2-ERG fusion genomic context in prostate cancer. This evidence concerns the gene TMPRSS2 and prostate cancer.